Home » Newsletters » BioWorld Science

BioWorld Science

April 6, 2020

View Archived Issues

A20's inflammation-fighting properties decoded

Discovery and preclinical evaluation of an oral nicotinic acetylcholine alpha7 receptor PAM

Discovery of ketone-linked benzimidazole-benzoxaborole hybrids for the treatment of onchocerciasis

JAM2 is recurrently mutated in families with recessive primary familial brain calcification

Capricor initiates compassionate use program for patients with severe COVID-19

Futura Medical presents further detailed data from FM57 phase III study of MED-3000

Horizon Therapeutics acquires LPA1 receptor antagonist for dcSSc

Positive interim data from phase IIb study of UGN-102

Mouse model of COPD established through use of intratracheal spray

Novel diet-induced obese rat model of AF

Optogenetic plaque model traces neurodegeneration in AD

Microbiome changes precede tumor development in CRC

Collaboration between UW-Madison, FluGen and Bharat Biotech to develop COVID-19 vaccine

Ivermectin, approved as an antiparasitic, inhibits SARS-CoV-2 in vitro

Inositec patents calcium oxalate crystallization inhibitors

Aprea Therapeutics divulges quinuclidine derivatives for cancer

Chinese investigators identify new TLR8 agonists

ViiV Healthcare presents compounds for HIV infection

New HER2 inhibitors identified by Suzhou Zanrong Pharma

SHR-1701 begins new phase I trials for advanced solid tumors and nasopharyngeal carcinoma

European Commission approves Rybelsus for type 2 diabetes

Union Therapeutics announces program with optimized salt form of niclosamide to treat COVID-19

FDA approves Reblozyl to treat anemia in MDS

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 26, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 23, 2026.
Biallelic variants in COX18 identified as cause of Charcot-Marie-Tooth disease
BioWorld Science
Charcot-Marie-Tooth (CMT) disease is a group of clinically and genetically heterogeneous sensorimotor peripheral neuropathies. It is the most frequent inherited...
Muted and missing M&As: JPM deals absent in 2026
BioWorld
For years, the J.P. Morgan Healthcare Conference (JPM) kicked off with splashy headlines of major M&A activity among biopharma companies, but in 2026, the hype...
Sumitomo’s DSP-3456 exerts antidepressant-like effects
BioWorld Science
About one-third of patients with major depressive disorder (MDD) are treatment resistant. Ketamine is very effective in treatment-resistant depression, but it is...